About The Jikei University Kashiwa Hospital
東京慈恵会医科大学附属柏病院 は、千葉県柏市にある大学病院である。東京慈恵会医科大学の附属病院である。略称は、慈恵医大柏病院。救命救急センター、千葉県災害拠点病院、地域がん診療連携拠点病院である。
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at The Jikei University Kashiwa Hospital
During the past decade, The Jikei University Kashiwa Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on
average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Jikei University Kashiwa Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Takeda" with 2 trials
sponsored, "Amgen" with 1 trials sponsored, "Kyowa Kirin Co., Ltd." with 1 trials sponsored and "Pfizer"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Jikei University Kashiwa Hospital"
#1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "Asahi Intech" with 1 trials as a collaborator, "Japan Lifeline" with 1 trials as a collaborator, "Kaneka Medical America LLC" with 1 trials as a collaborator and "Terumo Medical Corporation" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at The Jikei University Kashiwa Hospital
According to Clinical.Site data, the most researched conditions in "The Jikei University Kashiwa Hospital" are
"Ovarian Cancer" (2 trials), "Cardiovascular Disease" (1 trials), "Colitis, Ulcerative" (1 trials), "Coronary Occlusion" (1 trials) and "Fallopian Tube Cancer" (1 trials). Many other conditions were trialed in "The Jikei University Kashiwa Hospital" in a lesser frequency.
Clinical Trials Intervention Types at The Jikei University Kashiwa Hospital
Most popular intervention types in "The Jikei University Kashiwa Hospital" are "Drug" (7 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Guselkumab" (2 trials), "Archival Tumor Tissue Sample" (1 trials), "Avelumab" (1 trials) and "Bortezomib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The Jikei University Kashiwa Hospital
The vast majority of trials in "The Jikei University Kashiwa Hospital" are
7 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at The Jikei University Kashiwa Hospital
Currently, there are NaN active trials in "The Jikei University Kashiwa Hospital".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in The Jikei University Kashiwa Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in The Jikei University Kashiwa Hospital, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".